SANJIDA CABOT: Open Payments
NPI 1548522493 · CEDARHURST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 30 payments from 10 companies in 2025. Trend: 2023 $427 · 2024 $576 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $180 |
| Lilly USA, LLC | 3 | $90 |
| Amgen Inc. | 4 | $79 |
| Orexo US, Inc. | 4 | $63 |
| Exact Sciences Corporation | 2 | $49 |
| Indivior Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $37 |
| PFIZER INC. | 1 | $26 |
| ABBVIE INC. | 1 | $22 |
| Intra-Sana Laboratories | 1 | $14 |
Products named: AIRSUPRA, MOUNJARO, Zubsolv, OTEZLA, Cologuard Collection Kit, SUBLOCADE, Ozempic, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
